ClinicalTrials.Veeva

Menu

Using of Bone Marrow Stem Cell Concentrate with Platelet Rich Fibrin and Bone Graft in Bone Reconstruction of Upper Jaw Bony Cystic Defects, Comparing with Platelet Rich Fibrin with Bone Graft

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Not yet enrolling
Phase 3

Conditions

Maxillary Cyst

Treatments

Biological: platelet rich fibrin and bone graft
Biological: Bone marrow stem cells concentrate , platelet rich fibrin , bone graft

Study type

Interventional

Funder types

Other

Identifiers

NCT06662604
OMFS 3-3-18

Details and patient eligibility

About

Will the use of bone marrow stem cells with platelet rich fibrin enhance and accelerate the bone regeneration in the upper jaw cystic defects ?

Full description

Reconstruction of critical size bone defect in maxillofacial surgery is a great challenge, current practice of bone reconstruction still having problems like delay in bone regeneration (up to 12 months) and bone graft failure and low availability of autogenous bone graft.

last decade stem cells therapy gained great interest, in many studies Bone marrow stem cells showed promising result in bone regeneration enhancing .

Platelet Rich Fibrin PRF also capability of enhancing bone and tissue regeneration by releasing of certain protein molecules call growth factors that initiate sequential biological events resulting in stem cells migration into the site of bone defect and differentiation to bone formation cells (osteoblast cells ).

Enrollment

22 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age range 18-50 years
  • Patients with a critical size maxillary cyst. (>3 cm)
  • Patients that free of any significant medical conditions that could affect healing or outcomes.

Exclusion criteria

  • Patients with large jaw cyst that endanger vital structures
  • Patients with significant medical condition
  • age under 18 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

22 participants in 2 patient groups

Group A (Stem cells ,PRF group) intervention group
Experimental group
Treatment:
Biological: Bone marrow stem cells concentrate , platelet rich fibrin , bone graft
Group B (PRF group)
Active Comparator group
Treatment:
Biological: platelet rich fibrin and bone graft

Trial contacts and locations

0

Loading...

Central trial contact

Tareq El-Ghareeb, Professor; Motea Abdulsalm Sanad, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems